Not usual indication: Dasatinib is usually given for blast phase of chronic myeloid leukemia, targeting BcrABL Mutation, a genetic lesion not usually found in blast or Richter's transformation of CLL.
Answered 7/16/2015
2.5k views
4 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question